Displaying results 73 - 84 of 158
General Hepatology
Targeted lipidomics and fatty acids profiles reveal w-oxidation as a rescue pathway of inhibited -oxidation in a rat model of drug-associated microvesicular liver steatosis

Targeted lipidomics and fatty acids profiles reveal w-oxidation as a rescue pathway of inhibited -oxidation in a rat model of ...

ePosters
View
General Hepatology
Bariatric surgical interventions in steatotic liver disease (SLD): Mapping global research trends of the last two decades (2005-2024)

Bariatric surgical interventions in steatotic liver disease (SLD): Mapping global research trends of the last two decades (200...

ePosters
View
General Hepatology
The effect of obesity and hepatic steatosis on the course and outcomes of COVID 19-associated pneumonia in patients with metabolic dysfunction-associated steatotic liver disease

The effect of obesity and hepatic steatosis on the course and outcomes of COVID 19-associated pneumonia in patients with metab...

ePosters
View
General Hepatology
Prevalence of MASLD and its association with the consumption of sugar sweetened beverages among a non-communicable disease cohort in the rural district of Iringa, Tanzania

Prevalence of MASLD and its association with the consumption of sugar sweetened beverages among a non-communicable disease coh...

ePosters
View
General Hepatology
A prove-of-concept study of pioglitazone low dose vs standard dose for the treatment of metabolic dysfunction-associated steatohepatitis

A prove-of-concept study of pioglitazone low dose vs standard dose for the treatment of metabolic dysfunction-associated steat...

ePosters
View
General Hepatology
RIPK3 inhibition boosts hepatocyte energy and glucose metabolism while reducing inflammation and fibrosis under metabolic stress

RIPK3 inhibition boosts hepatocyte energy and glucose metabolism while reducing inflammation and fibrosis under metabolic stre...

ePosters
View
General Hepatology
Hepatic miRNA expression in experimental models of metabolic dysfunction-associated steatotic liver disease

Hepatic miRNA expression in experimental models of metabolic dysfunction-associated steatotic liver disease

ePosters
View
General Hepatology
Distinct roles of hepatic S100A10 and S100A11 in metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma

Distinct roles of hepatic S100A10 and S100A11 in metabolic dysfunction-associated steatotic liver disease and hepatocellular c...

ePosters
View
General Hepatology
The liver frailty index is a good reflection of muscle function and identifies increased frailty in patients with non-cirrhotic steatotic liver disease compared with healthy controls

The liver frailty index is a good reflection of muscle function and identifies increased frailty in patients with non-cirrhoti...

ePosters
View
General Hepatology
Severe metabolic dysfunction-associated steatotic liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota in people with HIV

Severe metabolic dysfunction-associated steatotic liver disease is associated with gut dysbiosis and shift in the metabolic fu...

ePosters
View
General Hepatology
Exploring the interplay between sarcopenia, liver and cardiovascular damage in non-cirrhotic MASLD patients: a genetic perspective

Exploring the interplay between sarcopenia, liver and cardiovascular damage in non-cirrhotic MASLD patients: a genetic perspec...

ePosters
View
General Hepatology
Risk factor awareness for liver disease in four United States cities

Risk factor awareness for liver disease in four United States cities

ePosters
View
Displaying results 73 - 84 of 158